Phenotypic alterations in liver cancer cells induced by mechanochemical disruption

Sci Rep. 2019 Dec 20;9(1):19538. doi: 10.1038/s41598-019-55920-2.

Abstract

Hepatocellular carcinoma (HCC) is a highly fatal disease recognized as a growing global health crisis worldwide. Currently, no curative treatment is available for early-to-intermediate stage HCC, characterized by large and/or multifocal tumors. If left untreated, HCC rapidly progresses to a lethal stage due to favorable conditions for metastatic spread. Mechanochemical disruption of cellular structures can potentially induce phenotypic alterations in surviving tumor cells that prevent HCC progression. In this paper, HCC response to mechanical vibration via high-intensity focused ultrasound and a chemical disruptive agent (ethanol) was examined in vitro and in vivo. Our analysis revealed that mechanochemical disruption caused a significant overproduction of reactive oxygen species (ROS) in multiple HCC cell lines (HepG2, PLC/PRF/5, and Hep3B). This led to a decrease in cell viability and long-term proliferation due to increased expression and activity of death receptors TNFR1 and Fas. The cells that survived mechanochemical disruption had a reduced expression of cancer stem cell markers (CD133, CD90, CD49f) and a diminished colony-forming ability. Mechanochemical disruption also impeded HCC migration and their adhesion to vascular endothelium, two critical processes in hematogenous metastasis. The HCC transformation to a non-tumorigenic phenotype post mechanochemical disruption was confirmed by a lack of tumor spheroid formation in vitro and complete tumor regression in vivo. These results show that mechanochemical disruption inhibits uncontrolled proliferation and reduces tumorigenicity and aggressiveness of HCC cells through ROS overproduction and associated activation of TNF- and Fas-mediated cell death signaling. Our study identifies a novel curative therapeutic approach that can prevent the development of aggressive HCC phenotypes.

MeSH terms

  • AC133 Antigen / metabolism
  • Animals
  • Apoptosis / genetics
  • Apoptosis / physiology
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Cell Proliferation / physiology
  • Cell Survival / physiology
  • Female
  • Hep G2 Cells
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Integrin alpha6 / metabolism
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Male
  • Mice
  • Neoplastic Stem Cells / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Thy-1 Antigens / metabolism
  • fas Receptor / metabolism

Substances

  • AC133 Antigen
  • Integrin alpha6
  • Reactive Oxygen Species
  • Receptors, Tumor Necrosis Factor, Type I
  • Thy-1 Antigens
  • fas Receptor